A Cross-sectional Study of COPD and Symptom Variability in MEA Countries

• Primary objective: To assess perception of daily and weekly variability of symptoms in stable GOLD C and D COPD patients and their impact on daily life activities
• Secondary objectives:

• To describe the current treatment practice for the management of GOLD C and D COPD in MEA countries and their adherence to the GOLD 2015 guidelines
• To compare patients' perception of symptoms variability and their impact on activities between Gold categories C and D
• To identify demographic, behavioral and clinical factors associated with symptoms variability.

Inclusion criteria

• Patients eligible for inclusion have to fulfill all of the following criteria:

• Stable GOLD C or D COPD patient under maintenance treatment, over 45 years, who provided signed informed consent;
• COPD diagnosis documented by spirometry performed in the past 12 months with an FEV1/FVC < 0.7 and an FEV1 < 50% predicted.

Exclusion criteria

Patients are not eligible for inclusion if they meet one of the following criteria:

• Patient with an ongoing COPD exacerbation*;
• Patient who has experienced an exacerbation* in the previous 3 months;
• History of asthma, allergic rhinitis, lung cancer or any other significant respiratory disease, such as tuberculosis, lung fibrosis or sarcoidosis;
• Inability to understand the study related questions;
• Mentally disabled patient or unable to read and write;
• Pregnant.
• Current participation in a clinical trial;